ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 786 filers reported holding ISHARES TR in Q3 2020. The put-call ratio across all filers is 1.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $321,608 | -1.6% | 2,490 | 0.0% | 0.06% | -4.7% |
Q4 2022 | $326,912 | +12.3% | 2,490 | 0.0% | 0.06% | +1.6% |
Q3 2022 | $291,000 | -50.3% | 2,490 | -50.0% | 0.06% | +5.0% |
Q2 2022 | $586,000 | +9.7% | 4,980 | +42.3% | 0.06% | -30.2% |
Q4 2021 | $534,000 | -5.7% | 3,500 | 0.0% | 0.09% | -21.1% |
Q3 2021 | $566,000 | -1.2% | 3,500 | 0.0% | 0.11% | -0.9% |
Q2 2021 | $573,000 | +20.9% | 3,500 | 0.0% | 0.11% | -6.8% |
Q3 2020 | $474,000 | -0.8% | 3,500 | 0.0% | 0.12% | -0.8% |
Q2 2020 | $478,000 | +26.8% | 3,500 | 0.0% | 0.12% | +4.4% |
Q1 2020 | $377,000 | -10.7% | 3,500 | 0.0% | 0.11% | +17.5% |
Q4 2019 | $422,000 | +21.3% | 3,500 | 0.0% | 0.10% | +12.8% |
Q3 2019 | $348,000 | -8.9% | 3,500 | 0.0% | 0.09% | -5.5% |
Q2 2019 | $382,000 | -92.5% | 3,500 | -92.4% | 0.09% | -85.0% |
Q1 2019 | $5,126,000 | +6.2% | 45,858 | -8.3% | 0.61% | -3.2% |
Q4 2018 | $4,826,000 | +17.2% | 50,028 | +48.1% | 0.63% | -27.9% |
Q3 2018 | $4,118,000 | -44.5% | 33,770 | -50.0% | 0.87% | +6.4% |
Q2 2018 | $7,416,000 | – | 67,540 | – | 0.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |